Leonard E Weisman Selected Research

Coinfection

9/2007	Prophylaxis with lactoferrin, a novel antimicrobial agent, in a neonatal rat model of coinfection.
4/2007	Neonatal coinfection model of coagulase-negative Staphylococcus (Staphylococcus epidermidis) and Candida albicans: fluconazole prophylaxis enhances survival and growth.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Leonard E Weisman Research Topics

Disease

10	Infections 04/2015 - 01/2004
6	Sepsis (Septicemia) 04/2015 - 06/2004
4	Staphylococcal Infections 05/2009 - 06/2004
3	Bacteremia 11/2012 - 01/2004
3	Respiratory Syncytial Virus Infections 04/2009 - 10/2002
2	Lung Diseases (Lung Disease) 08/2009 - 04/2006
2	Body Weight (Weight, Body) 07/2009 - 04/2007
2	Coinfection 09/2007 - 04/2007
1	Bronchopulmonary Dysplasia 12/2018
1	Cross Infection (Nosocomial Infection) 11/2011
1	Birth Weight (Birth Weights) 08/2011
1	Pneumonia (Pneumonitis) 08/2009
1	Respiratory Tract Infections (Respiratory Tract Infection) 04/2009
1	Weight Gain 04/2007
1	Vaccinia 04/2006
1	Heart Diseases (Heart Disease) 04/2006
1	Burns 06/2004
1	Streptococcal Infections (Streptococcal Infection) 01/2004
1	Necrotizing Enterocolitis 06/2003
1	Patent Ductus Arteriosus 06/2003

Drug/Important Bio-Agent (IBA)

6	Monoclonal AntibodiesIBA 04/2015 - 06/2004
4	CoagulaseIBA 05/2009 - 06/2004
3	pagibaximabIBA 08/2011 - 05/2009
2	Azithromycin (Zithromax)FDA LinkGeneric 12/2018 - 11/2012
2	LactoferrinIBA 04/2015 - 09/2007
2	Anti-Bacterial Agents (Antibiotics)IBA 11/2012 - 06/2004
2	Palivizumab FDA Link 04/2009 - 04/2006
1	Clarithromycin (Biaxin)FDA LinkGeneric 12/2018
1	Erythromycin (Erycette)FDA LinkGeneric 11/2012
1	P 11 (P-11)IBA 08/2011
1	Oxygen (Dioxygen)IBA 08/2009
1	lipoteichoic acidIBA 05/2009
1	motavizumab (Numax)IBA 04/2009
1	Immunoglobulin G (IgG)IBA 01/2009
1	Immunoglobulin M (IgM)IBA 01/2009
1	talactoferrin alfaIBA 09/2007
1	Anti-Infective Agents (Microbicides)IBA 09/2007
1	LysostaphinIBA 06/2007
1	Dihydrotachysterol (AT 10)IBA 04/2007
1	Fluconazole (Zonal)FDA LinkGeneric 04/2007
1	AntibodiesIBA 07/2006
1	Membrane Glycoproteins (Membrane Glycoprotein)IBA 04/2006
1	VaccinesIBA 04/2006
1	DNA VaccinesIBA 04/2006
1	Linezolid (Zyvox)FDA Link 06/2004
1	arbekacinIBA 06/2004
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2004
1	Indomethacin (Indometacin)FDA LinkGeneric 06/2003
1	Immunoglobulins (Immunoglobulin)IBA 10/2002

Therapy/Procedure

4	Therapeutics 04/2015 - 06/2003
2	Catheters 04/2015 - 06/2004
1	Hand Hygiene 04/2015
1	Patient Isolation 11/2011
1	Antibiotic Prophylaxis 08/2009
1	Punctures 01/2004
1	Ligation 06/2003